A Changing Landscape in Castration-Resistant Prostate Cancer Treatment

Prostate cancer (PC) is the leading cause of cancer and the second leading cause of cancer-death among men in the Western world. About 10–20% of men with PC present with metastatic disease at diagnosis, while 20–30% of patients diagnosed with localized disease will eventually develop metastases. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Felici, A., Pino, M. S., Carlini, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399094/
https://www.ncbi.nlm.nih.gov/pubmed/22826702
http://dx.doi.org/10.3389/fendo.2012.00085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399094/
https://www.ncbi.nlm.nih.gov/pubmed/22826702
http://dx.doi.org/10.3389/fendo.2012.00085

Ejemplares similares